A 38-year-old man is diagnosed with MEN 1 syndrome. Which of the following is NOT a typical endocrine manifestation of MEN 1?

Explanation

## MEN 1 Syndrome: Classic Triad **Key Point:** MEN 1 (Menin gene mutation) presents with the "3 P" rule: **P**arathyroid, **P**ancreas, **P**ituitary. ### Endocrine Manifestations of MEN 1 | Feature | Frequency | Details | |---------|-----------|----------| | **Primary hyperparathyroidism** | ~95% | Earliest manifestation; multiglandular hyperplasia | | **Pancreatic neuroendocrine tumors** | ~70% | Gastrinoma (Zollinger-Ellison), insulinoma, non-functional | | **Pituitary adenomas** | ~40% | Prolactinoma most common; also growth hormone, non-functional | | **Adrenal tumors** | ~40% | Usually non-functional adenomas | | **Carcinoid tumors** | ~10% | Thymic, bronchial, gastric | ### Why Primary Hyperaldosteronism is NOT typical of MEN 1 **High-Yield:** Primary hyperaldosteronism (Conn syndrome) is **NOT** an established endocrine manifestation of MEN 1. While adrenal adenomas occur in MEN 1, they are typically **non-functional** and do not cause hyperaldosteronism. Aldosterone-secreting adenomas are not part of the MEN 1 phenotype. **Clinical Pearl:** Primary hyperaldosteronism is associated with **MEN 4** (CDKN1B mutation) in rare cases, but NOT MEN 1. Confusion often arises because adrenal involvement is common in MEN 1, but these tumors do not produce excess aldosterone. ### MEN 1 Diagnostic Criteria 1. Two or more MEN 1-associated tumors, OR 2. One MEN 1-associated tumor + first-degree relative with MEN 1, OR 3. Germline *MENIN* gene mutation **Mnemonic:** **3 P's of MEN 1** — **P**arathyroid (hyperparathyroidism), **P**ancreas (neuroendocrine tumors), **P**ituitary (adenomas).